309 related articles for article (PubMed ID: 33116479)
1. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.
Mehner M; Kubelt C; Adamski V; Schmitt C; Synowitz M; Held-Feindt J
J Cancer Res Clin Oncol; 2020 Jan; 146(1):117-126. PubMed ID: 31844979
[TBL] [Abstract][Full Text] [Related]
3. A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment.
Hellmold D; Arnaldi P; Synowitz M; Held-Feindt J; Akbari M
Biomed Mater; 2023 Apr; 18(3):. PubMed ID: 37054732
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive and comparative studies on nanocytotoxicity of glyceryl monooleate- and phytantriol-based lipid liquid crystalline nanoparticles.
Jagielski J; Przysiecka Ł; Flak D; Diak M; Pietralik-Molińska Z; Kozak M; Jurga S; Nowaczyk G
J Nanobiotechnology; 2021 Jun; 19(1):168. PubMed ID: 34082768
[TBL] [Abstract][Full Text] [Related]
5. Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.
Hellmold D; Kubelt C; Daunke T; Beckinger S; Janssen O; Hauck M; Schütt F; Adelung R; Lucius R; Haag J; Sebens S; Synowitz M; Held-Feindt J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240419
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.
Caylioglu D; Meyer RJ; Hellmold D; Kubelt C; Synowitz M; Held-Feindt J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808494
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.
Rarokar NR; Saoji SD; Raut NA; Taksande JB; Khedekar PB; Dave VS
AAPS PharmSciTech; 2016 Apr; 17(2):436-45. PubMed ID: 26208439
[TBL] [Abstract][Full Text] [Related]
10. Topical Delivery of Erythromycin Through Cubosomes for Acne.
Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
[TBL] [Abstract][Full Text] [Related]
11. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
12. Formulation, In-Vitro and Ex-Vivo Evaluation of Tretinoin Loaded Cubosomal Gel for the Treatment of Acne.
Sureka S; Gupta G; Agarwal M; Mishra A; K Singh S; P Singh R; Sah SK; de Jesus A Pinto T; Dua K
Recent Pat Drug Deliv Formul; 2018; 12(2):121-129. PubMed ID: 29437029
[TBL] [Abstract][Full Text] [Related]
13. Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model.
Adamski V; Schmitt C; Ceynowa F; Adelung R; Lucius R; Synowitz M; Hattermann K; Held-Feindt J
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1475-1485. PubMed ID: 29858681
[TBL] [Abstract][Full Text] [Related]
14. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
15. Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies.
Faisal MM; Gomaa E; Ibrahim AE; El Deeb S; Al-Harrasi A; Ibrahim TM
AAPS PharmSciTech; 2024 May; 25(5):95. PubMed ID: 38710921
[TBL] [Abstract][Full Text] [Related]
16. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization.
Bhatt AB; Barnes TJ; Prestidge CA
Curr Drug Deliv; 2015; 12(1):47-55. PubMed ID: 25176029
[TBL] [Abstract][Full Text] [Related]
17. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a glioblastoma in vitro (in)complete resection dual co-culture model suitable for drug testing.
Schmitt C; Adamski V; Rasch F; Adelung R; Lucius R; Synowitz M; Hattermann K; Held-Feindt J
Ann Anat; 2020 Mar; 228():151440. PubMed ID: 31726206
[TBL] [Abstract][Full Text] [Related]
19. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin.
Peng X; Zhou Y; Han K; Qin L; Dian L; Li G; Pan X; Wu C
Drug Des Devel Ther; 2015; 9():4209-18. PubMed ID: 26345516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
